Covid-19: Arthritis drug tocilizumab reduces deaths in hospitalised patients, study shows
Jacqui Wise
Abstract
Covid-19: Arthritis drug tocilizumab reduces deaths in hospitalised patients, study shows Jacqui WiseThe anti-inflammatory treatment, tocilizumab, improves survival for patients hospitalised with covid-19, shortens the time to discharge, and reduces the need for a mechanical ventilator, results from the randomised evaluation of covid-19 therapy (Recovery) trial show. 1 1
Topics & Concepts
TocilizumabMedicineCoronavirus disease 2019 (COVID-19)Visitor patternWorld Wide WebInternet privacyComputer scienceInternal medicineProgramming languageDiseaseInfectious disease (medical specialty)COVID-19 Clinical Research StudiesCOVID-19 and Mental HealthCOVID-19 and healthcare impacts